Pocket Medicine: The Massachusetts General Hospital Handbook of Internal Medicine (51 page)

BOOK: Pocket Medicine: The Massachusetts General Hospital Handbook of Internal Medicine
10.49Mb size Format: txt, pdf, ePub
HEPATIC VASCULAR DISEASE

Portal vein thrombosis
(PVT) (
Al Phar Ther
2009;30:881;
J Hepatol
2012;56:S1)
• Definition: thrombosis, constriction or invasion of portal vein → portal HTN → varices. Isolated splenic vein thrombosis (eg, 2° to pancreatitis) → isolated gastric varices.

• Etiologies: cirrhosis, neoplasm (pancreas, HCC), abdominal infxn → pylephlebitis (infected thrombosis of PVT), hypercoag state (incl MPS), pancreatitis, IBD, surgery, trauma • Clinical manifestations
acute PVT
: can p/w pain; often asx and dx as incidental finding on U/S or CT if mesenteric vein involved may p/w intestinal infarct; if fever consider pylephlebitis
chronic PVT
: asx/incidental finding; may p/w s/s of portal HTN → hematemesis 2° variceal bleeding, splenomegaly, mild enceph; ascites uncommon unless cirrhosis
• Diagnostic studies: LFTs usually normal; U/S w/ Doppler, MRA, CT (I
+
), angiography;
“portal cavernoma” network of hepatopedal collaterals in chronic PVT—can rarely cause biliary obstruction and cholestatic LFTs = portal cholangiopathy (may require surgery)
• Treatment: eval for underlying cause (cirrhosis, MDS, hypercoag); if cirrhotic, Rx less clear
acute
: LMWH → warfarin × 6 mo, or indefinitely if irreversible cause (except cirrhosis),
chronic
: anticoag if noncirrhotic or hypercoag state; unclear if benefit > bleed risk
ppx
: LMWH may prevent PVT & liver decomp in advanced cirrhosis (
Gastro
2012;143:1253)
Varices: screen at dx; no evidence for 1° ppx of bleed; if bleed endoscopic Rx and bB. If refractory bleed consider TIPS, shunt. Isolated gastric varices 2° splenic vein thrombosis: splenectomy is curative.

Budd-Chiari syndrome
(
J Hepatol
2012;56:S1)
• Occlusion of hepatic vein(s) or IVC → sinusoidal congestion and portal HTN

• Etiol: ~50% due to myeloproliferative disorder a/w
JAK2
mutations (esp.
P. vera
), other hypercoag state, tumor invasion (HCC, renal, adrenal), IVC webs, trauma,
1
/
4
idiopathic • Symptoms: hepatomegaly, RUQ pain, ascites, dilated venous collaterals • Dx: ± ↑ aminotransferases & AΦ; Doppler U/S of hepatic veins (85% Se & Sp); CT (I
+
) or MRI/MRV → vein occlusion or ↑ caudate lobe (separate venous drainage); “spider-web” pattern on hepatic venography; liver bx showing congestion (r/o right-sided CHF) • Treatment: anticoag (LMWH → warfarin); consider thrombolysis acutely; if short stenosis stent may be possible; consider TIPS (↑ occlusion risk c/w side-to-side portocaval shunt); liver transplant if hepatic failure or failed shunt (
J Gastro Surg
2012;16:286)
Sinusoidal obstruction syndrome
(SOS) (
J Hepatol
2012;56:S1)

Occlusion of hepatic venules and sinusoids (formerly veno-occlusive disease
) • Etiologies: HSCT, chemo (esp. cyclopho), XRT, Jamaican bush tea • Clinical manifestations: hepatomegaly, RUQ pain, ascites, weight gain, ↑ bilirubin • Dx: U/S w/ reversal of portal flow, but often not helpful; dx made clinically (↑ bili, wt gain/ascites and RUQ pain) or, if necessary, by liver bx or HVPG (>10 mmHg) • Treatment (20% mortality): supportive; ? defibrotide (adenosine agonist ↑ TPA levels) • Ppx: defibrotide; ursodeoxycholic acid for high-risk HSCT pop; ? use of low-dose heparin
Figure 3-8 
Hepatic vasculature
ASCITES

Pathophysiology

• Portal hypertension → systemic vasodilatation (? due to release of NO) → ↓ effective arterial volume → renal Na retention • ↓ serum oncotic pressure from hypoalbuminemia; ↑ hepatic lymph production

Symptoms

• ↑ abd girth, wt gain, new abd hernia, abd pain, dyspnea, nausea, early satiety
Evaluation
(
JAMA
2008;299:1166;
Hepatology
2009;29:2087)
• Physical exam: flank dullness (NPV
90%; >1500 mL needed), shifting dullness (Se
83%) •
Radiologic: U/S
detects >100 mL; MRI/CT (also help with Ddx) •
Paracentesis
(
NEJM
2006
;
355:e21;
Dig Dis Sci
2007;52:3307): perform in all Pts w/ new ascites and consider in all hospitalized cirrhotics w/ ascites; complic. <1% (bleeding, but risk not related to PT or plt count;
Hepatology
2004;40:484); U/S ↑ success but does not ↓ complic.

Serum-ascites albumin gradient (SAAG)
: ~95% acc. for portal HTN (
Annals
1992;117:215)
≥1.1 g/dL → portal hypertension related; <1.1 g/dL → non–portal hypertension related
if portal HTN + another cause (seen in ~5% of cases) SAAG still ≥1.1
if known cirrhosis and SAAG <1.1 but no other readily identifiable cause, likely just cirrhosis (
Am J Gastro
2009;104:1401)
• Ascites fluid total protein (AFTP): useful when SAAG ≥1.1 to distinguish cirrhosis (AFTP <2.5 g/dL) from cardiac ascites (AFTP ≥ 2.5 g/dL) •
Rule out infection
: cell count w/ diff + Gram stain/cx define bacterial peritonitis (see later); bedside inoculation of cx bottles ↑ yield to 90% (
Gastro
1988;95:1351) fungal cx if prolonged hosp, abx use; AFB cx + adenosine deaminase to r/o TB
• Other tests: amylase (pancreatitis, gut perforation); triglycerides (chylous ascites); cytology (peritoneal carcinomatosis, ~95% Se w/ 3 samples); LDH, glc, CEA, AΦ (perforation)
Treatment

If 2° to portal HTN (see “Cirrhosis” for details): ↓ Na intake
+
diuretics
(spironolactone + furosemide); if refractory → large-volume paracentesis or TIPS
• If non–portal HTN related: depends on underlying cause (TB, malignancy, etc.) • Vaptans ↑ Na, mobilize ascites, but no morb/mort benefit (
Al Pharm & Ther
2012;36:619)
Bacterial peritonitis
(
Gut
2012;61:297)

SBP/CNNA
: seen in cirrhosis (qv) b/c ascites have ↓ opsonins; rare in other causes •
NNBA
: often resolves w/o Rx; follow closely → Rx only if sx or persistently culture

Secondary
intra-abdominal abscess or perforation so often polymicrobial ascitic fluid TP >1 g/dL, glc <50 mg/dL, LDH >225 U, CEA >5, AΦ >240 Rx: 3rd-gen. ceph + metronidazole; urgent abdominal imaging ± ex lap •
Peritoneal dialysis-associated
: cloudy fluid, abd pain, fever, nausea pathogens: 70% GPC, 30% GNR; Rx: vanc + gent (IV load, then administer in PD)
BILIARY TRACT DISEASE

CHOLELITHIASIS (GALLSTONES)

Epidemiology & pathogenesis
(
J Hep
2008;48:S124)
• >10% adults in the U.S. have gallstones; a/w ↑ overall mortality (
Gastro
2011;140:508) • Bile = bile salts, phospholipids, cholesterol; ↑ cholesterol saturation in bile + accelerated nucleation + gallbladder hypomotility → gallstones • Risk factors:
; South, Central, Native American; ↑ age (>40 y), obesity, pregnancy, TPN, rapid ↓ wt; drugs (OCPs, estrogen, clofibrate, octreotide, ceftriaxone); ileal disease • ? statin use >1 y ↓ risk of sx gallstones & cholecystectomy (
JAMA
2009;302:2001)
Types of gallstones

• Cholesterol (90%): 2 subtypes
mixed: contain >50% cholesterol; typically smaller, multiple stones
pure: 100% cholesterol; larger, yellow, white appearance
• Pigment (10%)
Black:
unconjugated bilirubin (chronic hemolysis, cirrhosis) and calcium
Brown:
stasis & infection in bile ducts → bacteria deconjugate bilirubin → precipitates w/ calcium; seen w/ duodenal diverticula, biliary strictures, parasites

Other books

High Anxiety by Hughes, Charlotte
Evil Relations by David Smith with Carol Ann Lee
Stay Until We Break by Mercy Brown
V. by Thomas Pynchon
A Bit of Me by Bailey Bradford
Lovesick by Alex Wellen
Helen Hath No Fury by Gillian Roberts
Mollify by Xavier Neal